Osteoclast inhibition in postmenopausal breast cancer

Is the evidence too strong to ignore?

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)2392-2394
Number of pages3
JournalCancer
Volume123
Issue number13
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Osteoclasts
Breast Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Osteoclast inhibition in postmenopausal breast cancer : Is the evidence too strong to ignore? / Stopeck, Alison T.

In: Cancer, Vol. 123, No. 13, 01.07.2017, p. 2392-2394.

Research output: Contribution to journalEditorial

@article{8a860e6a5994402ebca4928ef6afb80e,
title = "Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?",
author = "Stopeck, {Alison T}",
year = "2017",
month = "7",
day = "1",
doi = "10.1002/cncr.30678",
language = "English (US)",
volume = "123",
pages = "2392--2394",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "13",

}

TY - JOUR

T1 - Osteoclast inhibition in postmenopausal breast cancer

T2 - Is the evidence too strong to ignore?

AU - Stopeck, Alison T

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85018986379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018986379&partnerID=8YFLogxK

U2 - 10.1002/cncr.30678

DO - 10.1002/cncr.30678

M3 - Editorial

VL - 123

SP - 2392

EP - 2394

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 13

ER -